NeuroOne Ablation System Treats Trigeminal Neuralgia
A Cleveland patient reports immediate relief after undergoing a minimally invasive nerve ablation procedure.
Updated on Oct. 27, 2026 in Stroke
Live Poll
Do you believe new surgical technologies provide meaningful, lasting relief for chronic pain conditions?
A patient at University Hospitals in Cleveland received successful treatment for trigeminal neuralgia using the FDA-cleared OneRF Trigeminal Nerve Ablation System. The procedure provided immediate relief for the patient, who had suffered from facial pain for seven years.
Why it matters
The case highlights the application of the OneRF system, which enables physicians to test multiple nerve locations through a single probe insertion to address chronic facial pain. This minimally invasive approach represents an alternative for patients struggling with debilitating nerve conditions.
The OneRF Trigeminal Nerve Ablation System enables physicians to test multiple nerve locations through a single probe insertion. The procedure typically lasts between 20 and 30 minutes.
The players
NeuroOne
This Eden Prairie, Minnesota-based medical technology company develops and commercializes innovative diagnostic and ablation systems.
Natisha Long
She is the patient who underwent the successful trigeminal nerve ablation procedure at University Hospitals.
University Hospitals
This Cleveland-based health system serves as a hub for advanced medical procedures and clinical patient care.
The details
Natisha Long underwent the procedure at University Hospitals to manage the persistent facial pain she endured for seven years. The technology allows surgeons to efficiently target specific nerves, reducing the complexity of the intervention.
Timeline
October 27, 2026: NeuroOne highlighted the successful patient outcome.
The Big Picture
The successful use of the OneRF Trigeminal Nerve Ablation System demonstrates a shift toward more precise, efficient interventional methods for managing chronic neuropathic conditions. This clinical outcome highlights how specialized ablation technologies are evolving to streamline complex nerve procedures.
For patients suffering from trigeminal neuralgia, this procedure offers a potential path to immediate pain relief through a 20 to 30-minute intervention. Prospective patients should consult their neurologist to determine if this FDA-cleared technology is a viable treatment option for their specific condition.
The takeaway
Chronic trigeminal neuralgia significantly impacts quality of life, but targeted ablation procedures are offering faster, less invasive alternatives for relief. Patients should discuss the long-term clinical data and specific procedure benefits with their medical providers.
Further reading
For more information on neurological advancements, visit the Stroke section.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you believe new surgical technologies provide meaningful, lasting relief for chronic pain conditions?
